$2.220
0.000 (0.00%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TXMD Prediction & Forecast by Similar Chart Analysis
Alphio's TXMD stock price prediction model matches the current TherapeuticsMD Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.23 (+0.60%). The 1-week path is $2.28 (+2.86%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy TherapeuticsMD Inc Stock?
TherapeuticsMD Inc (TXMD) is a good buy right now due to its recent price increase of 7.77% over the last five days and a strong forward P/E ratio of 2.33, suggesting undervaluation relative to future earnings. Additionally, the stock has shown a remarkable 109.43% increase over the past year, indicating strong momentum. However, a risk to consider is the negative net income reported in Q2 2026, which was $0, highlighting ongoing profitability challenges.
TXMD stock price ended at $2.22 on Friday, after rising 0.00%
TherapeuticsMD Inc (TXMD) last closed at $2.22, gaining +0.00%. These facts feed the 1-day and 1-week TXMD price prediction above.
Analyst Consensus
TherapeuticsMD Inc (TXMD): 8 buy, 1 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
TherapeuticsMD Inc (TXMD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches TXMD, ranked by similarity.
Seasonality analysis for TXMD
Historically the probability of a positive August return for TXMD is 31.75%. March offers the highest probability of a positive month at 49.21%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.